Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report

Immune checkpoint inhibitors (ICIs) have become a standard treatment for various cancers, but their use is often associated with immune-related adverse events (irAEs), including cutaneous irAEs (cirAEs). Here, we report a rare case of subacute cutaneous lupus erythematosus (SCLE) induced by sintilim...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenxi Zhang, Xiaoying Zhang, Jiali Liang, Yifei Liu, Jialong Chen, Qi Wang, Changxing Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
sintilimab
PD-1 inhibitor
immune-related adverse events
subacute cutaneous lupus erythematosus
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1544312/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items